GlassScriptPhysician profile
Sheila Mercado
NPI 1073947834
$5,857.61
in general payments reported to CMS, 2019-2025
13 companies · $119 in 2025
The $119 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,249 · 2020: $360 · 2021: $484 · 2022: $1,450 · 2023: $835 · 2024: $1,361 · 2025: $119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,250 · Consulting Fee: $1,000 · Education: $64.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,250.09 |
| Consulting Fee | $1,000.00 |
| Education | $64.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,343.90 | 2022-2024 | Inpen Smart Insulin Delivery System, Minimed 780g |
| Astrazeneca Pharmaceuticals LP | $967.84 | 2019-2024 | Farxiga, Lokelma |
| Boehringer Ingelheim Pharmaceuticals, INC. | $672.29 | 2019-2025 | Jardiance |
| Eli Lilly Export S.A. Puerto Rico Branch | $591.31 | 2019-2024 | Trulicity, Mounjaro, Lyumjev |
| Merck Sharp & Dohme LLC | $464.88 | 2019-2024 | Janumet, Januvia, Segluromet |
| Janssen Pharmaceuticals, INC | $406.24 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $389.23 | 2019-2023 | |
| Novo Nordisk INC | $285.67 | 2019-2024 | Ozempic, Rybelsus |
| Amgen INC. | $216.72 | 2019 | |
| Dexcom, INC. | $210.50 | 2019-2023 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $198.84 | 2022-2025 | Mounjaro, Jardiance |
| Abbott Laboratories | $98.96 | 2021-2022 | |
| Abbvie INC. | $11.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheila Mercado listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.